Totally agree Old Eng, I find ResMed frequently gets sold down on results only to recover in US led trading in the following week or 2.
Analysts seemed to like the results in general.
I suspect arb traders are not as active when results are freshly released and Aus markets are hence susceptible to a sell down, particularly when only a small divie is visible to a dividend loving local market.
Ann: FORM 10Q for Qtr ended December, 2022, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.52 |
Change
-0.860(2.58%) |
Mkt cap ! $20.84B | |||
| Open | High | Low | Value | Volume |
| $32.39 | $32.59 | $32.39 | $19.10M | 587.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 453 | $32.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.52 | 2542 | 23 |
View Market Depth
| Last trade - 12.58pm 08/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |